Ascendis Pharma A (ASND) Capital Expenditures (QoQ) (2014 - 2024)
Ascendis Pharma A (ASND) Capital Expenditures (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -39.25% |
| Jun 30, 2024 | -70.36% |
| Mar 31, 2024 | -418.93% |
| Dec 31, 2023 | 106.38% |
| Sep 30, 2023 | -119.75% |
| Jun 30, 2023 | 58.48% |
| Mar 31, 2023 | 69.82% |
| Dec 31, 2022 | -20.99% |
| Sep 30, 2022 | 19.79% |
| Jun 30, 2022 | 7.22% |
| Mar 31, 2022 | -108.79% |
| Dec 31, 2021 | 465.80% |
| Sep 30, 2021 | -208.92% |
| Jun 30, 2021 | 11.15% |
| Mar 31, 2021 | -111.48% |
| Dec 31, 2020 | 842.99% |
| Sep 30, 2020 | -12.69% |
| Jun 30, 2020 | 25.52% |
| Mar 31, 2020 | -166.65% |
| Dec 31, 2019 | 831.26% |